EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating Neutralizing Antibodies in Hantavirus-Infected Patients Using Authentic Virus and Recombinant Vesicular Stomatitis Virus Systems

Punya Shrivastava-Ranjan iD, Jamie A Kelly iD, Laura K McMullan iD, Deborah Cannon, Laura Morgan, Payel Chatterjee iD, Shilpi Jain, Joel M Montgomery, Mike Flint iD, César G Albariño, Christina F Spiropoulou

Viruses · 2025

DOI: 10.3390/v17050723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Punya Shrivastava-Ranjan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, …. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Antibodies, Viral, Orthohantavirus, Hantavirus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hantaviruses, including the Sin Nombre virus (SNV) and Andes virus (ANDV), are associated with severe global health risks, causing high mortality rates in hantavirus pulmonary syndrome (HPS) patients. Neutralizing antibodies are essential for virus clearance and survival, making neutralization assays critical for understanding immunity and evaluating therapeutic strategies. In this study, we developed a recombinant vesicular stomatitis virus (VSV)-based surrogate system expressing SNV and ANDV glycoproteins (GPCs), enabling neutralization studies under biosafety level 2 conditions. The neutralization titers obtained with the VSV-based system closely matched the findings from authentic hantavirus assays performed under biosafety level 3 conditions, confirming its potential as a useful tool for determining immune responses and advancing hantavirus research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingAntibodies, ViralOrthohantavirusHantavirus InfectionsVesicular stomatitis Indiana virusVesiculovirusHumansNeutralization TestsAnimalsSin Nombre virusHantavirus Pulmonary SyndromeVero Cells

Stichwörter der Autor:innen

Andes virusSin Nombre virushantaviridaehemorrhagic feverorthohantavirus

Substanzen

Antibodies, NeutralizingAntibodies, Viral

Autor:innen und Institutionen

  • Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

ORCID-Profile: Punya Shrivastava-Ranjan, Jamie A Kelly, Laura K McMullan, Payel Chatterjee, Mike Flint

Zitieren

APA

Shrivastava-Ranjan, P., Kelly, J. A., McMullan, L. K., Cannon, D., Morgan, L., Chatterjee, P., Jain, S., Montgomery, J. M., Flint, M., Albariño, C. G., & Spiropoulou, C. F. (2025). Evaluating Neutralizing Antibodies in Hantavirus-Infected Patients Using Authentic Virus and Recombinant Vesicular Stomatitis Virus Systems. Viruses. https://doi.org/10.3390/v17050723

Vancouver

Shrivastava-Ranjan P, Kelly JA, McMullan LK, Cannon D, Morgan L, Chatterjee P, et al. Evaluating Neutralizing Antibodies in Hantavirus-Infected Patients Using Authentic Virus and Recombinant Vesicular Stomatitis Virus Systems. Viruses. 2025. doi:10.3390/v17050723

BibTeX
@article{ShrivastavaRanjan2025,
  author = {Shrivastava-Ranjan, Punya and Kelly, Jamie A and McMullan, Laura K and Cannon, Deborah and Morgan, Laura and Chatterjee, Payel and Jain, Shilpi and Montgomery, Joel M and Flint, Mike and Albariño, César G and Spiropoulou, Christina F},
  title = {Evaluating Neutralizing Antibodies in Hantavirus-Infected Patients Using Authentic Virus and Recombinant Vesicular Stomatitis Virus Systems},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17050723}
}
Kostenlos starten →